HIV TREATMENT BASED ON INDIVIDUALIZED VIRAL BURDEN ANALYSIS
Executive Summary
HIV TREATMENT BASED ON INDIVIDUALIZED VIRAL BURDEN ANALYSIS warrants study, American Foundation, for AIDS Research Clinical Research Director Ellen Cooper, MD, said at a press roundtable on individualized HIV therapy sponsored by Hoffmann-La Roche and AmFAR in New York City July 12. "If you can monitor the viral Liter and intervene with a more effective drug or combination of drugs" when the Liter begins to rise, Cooper postulated, "you will be able to prolong the asymptomatic state."